These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6428460)

  • 21. Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3' (Arg136-->His): association with mild dyslipidemia and double pre-beta very low density lipoproteins.
    Minnich A; Weisgraber KH; Newhouse Y; Dong LM; Fortin LJ; Tremblay M; Davignon J
    J Lipid Res; 1995 Jan; 36(1):57-66. PubMed ID: 7706948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins.
    Falko JM; Schonfeld G; Witztum JL; Kolar JB; Weidman SW; Steelman R
    J Clin Endocrinol Metab; 1980 Mar; 50(3):521-8. PubMed ID: 7358833
    [No Abstract]   [Full Text] [Related]  

  • 24. Functionally inactive apolipoprotein E3 in a type III hyperlipoproteinaemic patient.
    Havekes LM; Gevers Leuven JA; van Corven E; de Wit E; Emeis JJ
    Eur J Clin Invest; 1984 Feb; 14(1):7-11. PubMed ID: 6321197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different mobility in SDS--polyacrylamide gel electrophoresis of apolipoprotein E from phenotypes apo E-N and Apo E-D.
    Utermann G; Weber W; Beisiegel U
    FEBS Lett; 1979 May; 101(1):21-6. PubMed ID: 221251
    [No Abstract]   [Full Text] [Related]  

  • 26. Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemia.
    Rall SC; Weisgraber KH; Innerarity TL; Mahley RW
    J Clin Invest; 1983 Apr; 71(4):1023-31. PubMed ID: 6300187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E phenotypes of normo- and hyperlipoproteinemia in Japanese.
    Sano R; Abe R; Oikawa S; Fujii Y; Hori S; Suzuki N; Toyota T; Goto Y
    Tohoku J Exp Med; 1988 Mar; 154(3):297-303. PubMed ID: 3376106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the protein composition of human serum very low density lipoproteins: demonstration of the beta 2-glycoprotein-I.
    Polz E; Kostner GM; Holasek A
    Hoppe Seylers Z Physiol Chem; 1979 Aug; 360(8):1061-7. PubMed ID: 229068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
    Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia.
    Yamamura T; Yamamoto A; Sumiyoshi T; Hiramori K; Nishioeda Y; Nambu S
    J Clin Invest; 1984 Oct; 74(4):1229-37. PubMed ID: 6480826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia.
    Moriyama K; Sasaki J; Matsunaga A; Arakawa F; Takada Y; Araki K; Kaneko S; Arakawa K
    Biochim Biophys Acta; 1992 Sep; 1128(1):58-64. PubMed ID: 1356443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of infusion of normal plasma on lipoproteins in type III hyperlipoproteinemia.
    Stuyt PM; Demacker PN; van 't Laar A
    Horm Metab Res; 1981 Dec; 13(12):715-6. PubMed ID: 7319472
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic polymorphism of apolipoprotein E: a variant form of apolipoprotein E2 distinguished by sodium dodecyl sulfate--polyacrylamide gel electrophoresis.
    Utermann G; Weisgraber KH; Weber W; Mahley RW
    J Lipid Res; 1984 Apr; 25(4):378-82. PubMed ID: 6726088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparative electrophoresis of human apolipoprotein E: an improved method.
    Meunier S; Gambert P; Desgres J; Lallemant C
    J Lipid Res; 1986 Dec; 27(12):1324-7. PubMed ID: 3559395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia.
    Mahley RW; Angelin B
    Adv Intern Med; 1984; 29():385-411. PubMed ID: 6369930
    [No Abstract]   [Full Text] [Related]  

  • 36. Characterization of a unique human apolipoprotein E variant associated with type III hyperlipoproteinemia.
    Zannis VI; Breslow JL
    J Biol Chem; 1980 Mar; 255(5):1759-62. PubMed ID: 7354052
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of variant apolipoprotein E by isoelectric focusing and restriction isotyping in a patient with type III hyperlipoproteinemia.
    Nassar BA; McPherson R; Lamothe EM; al-Sultan AI; Zhang ZJ; Rosenblatt DS
    Clin Chem; 1991 Jul; 37(7):1308. PubMed ID: 1677318
    [No Abstract]   [Full Text] [Related]  

  • 38. Rapid isolation of apolipoprotein E from human plasma very low density lipoproteins by molecular sieve high performance liquid chromatography.
    Pfaffinger D; Edelstein C; Scanu AM
    J Lipid Res; 1983 Jun; 24(6):796-800. PubMed ID: 6886568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fast protein chromatofocusing of human very-low-density lipoproteins.
    Weisweiler P; Friedl C; Schwandt P
    Biochim Biophys Acta; 1986 Jan; 875(1):48-51. PubMed ID: 3940536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fat restriction alters the composition of apolipoprotein B-100 containing very low-density lipoproteins in humans.
    Weisweiler P; Janetschek P; Schwandt P
    Am J Clin Nutr; 1986 Jun; 43(6):903-9. PubMed ID: 3717064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.